|Articles|October 18, 2016

How antibiotic overuse could lead to hay fever (VIDEO)

For Contemporary Pediatrics, Dr Bobby Lazzara explains an abstract presented at the European Respiratory Society International Congress that examined whether early antibiotic exposure increases the risk of allergic rhinitis.

For Contemporary Pediatrics, Dr Bobby Lazzara explains an abstract presented at the European Respiratory Society International Congress that examined whether early antibiotic exposure increases the risk of allergic rhinitis.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

Latest CME

Multimedia

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Multimedia

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

How antibiotic overuse could lead to hay fever (VIDEO)

Newsletter

Related Content

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

Eye spy: A case of a corneal lesion in an 8-year-old girl

Prepandemic diet quality similar among WIC participants and income-eligible nonparticipants

Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults

Latest CME

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

Eye spy: A case of a corneal lesion in an 8-year-old girl

Prepandemic diet quality similar among WIC participants and income-eligible nonparticipants

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy